Novo Nordisk Stock Plunges 21.83% Amid Lawsuits Over Growth Misrepresentation 660M Trading Volume Ranks 118th in Market Activity

On August 27, 2025, Novo Nordisk (NVO) rose 1.99% with a trading volume of $0.66 billion, ranking 118th in market activity. The stock’s recent volatility has drawn attention amid ongoing legal scrutiny over alleged misrepresentations regarding its growth prospects.

Shareholders are filing lawsuits alleging that the company overstated its ability to capitalize on the compounded GLP-1 market during the period from May 7 to July 28, 2025. The suits claim Novo downplayed the impact of personalized compounding exceptions and exaggerated patient transition potential to branded alternatives. This led to a significant price drop on July 29, 2025, following a revised outlook citing slower market expansion and competitive pressures. The stock fell nearly 21.83% in a single session after the announcement.

Investors who purchased shares during the alleged misrepresentation period are seeking legal representation to pursue claims. Class action deadlines extend to September 30, 2025, with plaintiffs advised to register for case updates. The lawsuits focus exclusively on Novo’s disclosures, with no mention of unrelated market participants or broader sector trends.

Here is some news for you to read: 1. ENGO Eyewear's ENGO 2 Launch: ENGO Eyewear has introduced ENGO 2, its lightest and most technologically advanced smart eyewear for sports, now available at $329. 2. Healthy Extracts' Whitney Johns Products on Amazon: Healthy Extracts Inc. expanded its offerings by launching Whitney Johns-branded natural health and fitness products on Amazon.com. 3. Jeffry M Householder's Net Worth and Insider Trading: Chesapeake Utilities Corp's CEO, Jeffry M Householder, has a net worth of at least $4 million as of September 23, 2023. 4. Global Smart Shelves Market Report 2022: The global Smart Shelves market is projected to grow from $3.0 billion in 2022 to $8.3 billion by 2027. 5. Palantir Class Action Lawsuit: Palantir Technologies Inc. faces a class action securities lawsuit over alleged misleading statements about investments and revenue trends.